You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,591.3% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -2,056.5 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 322.8 | n/a |
| Price / Book value | -332.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 88.8% | n/a |
| PBT | 0.0% | n/a |
| EPS | 0.0% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 0.20 | -0.53 | -5.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 0.46 | -0.72 | -8.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 0.34 | -3.64 | -26.00p | -23.7 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 0.27 | -5.93 | -0.42p | -1,690.5 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 0.51 | -8.35 | -0.62p | -1,096.8 | 0.0 | n/a | n/a | 0.0% |
| 4basebio losses widen as it progresses commercial development Sharecast News | 27 Sep |
|---|---|
| 4basebio to provide synthetic DNA to tier-one pharma firm Sharecast News | 10 Apr |
| 4basebio client gets approval to start trial in Australia Sharecast News | 21 Mar |
| 4basebio Plc - Holding(s) in Company | 03-Oct-24 13:25 |
|---|---|
| 4basebio Plc - Holding(s) in Company | 03-Oct-24 13:25 |
| 4basebio Plc - Half-year Report | 27-Sep-24 07:00 |
| 4basebio Plc - Update re Equity Issuance, Secondary Sale and the board | 09-Sep-24 14:38 |
| 4basebio Plc - Strategic Advisory Board & Appointment of Director | 08-Aug-24 15:38 |